1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Invitae Acquires Ciitizen

M&A Deal Summary

Invitae Acquires Ciitizen

On September 7, 2021, Invitae acquired information technology company Ciitizen for 325M USD

Acquisition Highlights
  • This is Invitae’s 2nd transaction in the Information Technology sector.
  • This is Invitae’s largest (disclosed) transaction.
  • This is Invitae’s 12th transaction in the United States.
  • This is Invitae’s 6th transaction in California.

M&A Deal Summary
Date 2021-09-07
Target Ciitizen
Sector Information Technology
Buyer(s) Invitae
Deal Type Add-on Acquisition
Deal Value 325M USD

Target

Ciitizen

Palo Alto, California, United States
Ciitizen is a healthcare technology company helping patients get full control of their medical records to access more personal treatment options including participation in research and clinical trials. Ciitizen was founded in 2017 and is based in Palo Alto, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Invitae

San Francisco, California, United States
Category Company
Founded 2010
Sector Life Science
Employees1,700
Revenue 516M USD (2022)
DESCRIPTION

Invitae is a genetic information company diagnostics for hereditary disorders. Invitae was founded in 2010 and is based in San Francisco, California.

DEAL STATS #
Overall 13 of 13
Sector: Information Technology M&A 2 of 2
Type: Add-on Acquisition M&A Deals 13 of 13
State: California M&A 6 of 6
Country: United States M&A 12 of 12
Year: 2021 M&A 2 of 2
Size (of disclosed) 1 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-05 Genosity

Iselin, New Jersey, United States

Genosity is a genomics company offering innovative software and laboratory solutions to enable development and deployment of complex sequencing based tests. Genosity is based in Iselin, New Jersey.

Buy $200M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-20 ArcherDX

Boulder, Colorado, United States

ArcherDX is a genomic analysis company democratizing precision oncology through a suite of products and services that are highly accurate, personal, actionable, and easy to use in local settings. ArcherDX was formed in 2013 and is headquartered in Boulder, Colorado.

Sell $48M
Mergr

Solution for

Product

Company

Legal